Home > Node > Subnode Tafi Ishii, H. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl. 12: 717-7192004ISSN/ISBN: 0047-1852 PMID: 15658433 Document Number: 578321 Document emailed within 1 workday Purchase for $29.90 Secure & encrypted paymentsRelated DocumentsSchroeder, V.; Wilmer, M.; Buehler, B.; Kohler, H.P. 2006: TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays Thrombosis and Haemostasis 96(2): 236-237Kostka, H.; Kuhlisch, E.; Schellong, S.; Siegert, G. 2003: Polymorphisms in the TAFI Gene and the Risk of Venous Thrombosis Clinical Laboratory 49(11-12): 645-647Brouwers, G-Jan.; Leebeek, F.W.G.; Tanck, M.W.T.; Wouter Jukema, J.; Kluft, C.; de Maat, M.P.M. 2003: Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris Thrombosis and Haemostasis 90(1): 92-100Colucci, M.; Pentimone, A.; Binetti, B.M.; Cramarossa, M.; Piro, D.; Semeraro, N. 2002: Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin Thrombosis and Haemostasis 88(2): 282-287Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486